Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study

Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study

Background: The purpose of this study was to compare the efficacy and safety of utidelone plus capecitabine for advanced first-line versus second-line or above therapy in metastatic breast cancer patients who had previously received anthracycline and taxane. At the same time, we compared the efficac...

Full description

Bibliographic Details
Main Authors: Pingping Bi, Xi Wang, Rui Liu, Xiuqin Li, Shanrong Wei, Jiawen Zhao, Xin Tan, Fan Zhang, Qing Mao, Ying Zhang, Baoyan Tang, Xueqiong Xun, Rong Guo, Kai Zheng, Shaoqiang Zhou, Shicong Tang
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Surgery Open Science
Subjects:
Metastatic breast cancer
Utidelone
Capecitabine
Vinorelbine
First-line therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2589845023000921

Internet

http://www.sciencedirect.com/science/article/pii/S2589845023000921

Similar Items